SPONSOR
Hebei Medical University Fourth Hospital
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Lung AdenocarcinomaBreast CancerColon CancerEsophageal Squamous Cell CarcinomaRectal Cancer
Hebei Medical University Fourth Hospital is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Lung Adenocarcinoma, Breast Cancer, Colon Cancer, Esophageal Squamous Cell Carcinoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hebei Medical University Fourth Hospital
How many clinical trials has Hebei Medical University Fourth Hospital sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Hebei Medical University Fourth Hospital, of which 5 are actively recruiting participants. These trials cover conditions including Lung Adenocarcinoma, Breast Cancer, Colon Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hebei Medical University Fourth Hospital research focus on?
Hebei Medical University Fourth Hospital clinical trials span Lung Adenocarcinoma, Breast Cancer, Colon Cancer, Esophageal Squamous Cell Carcinoma, Rectal Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hebei Medical University Fourth Hospital clinical trial?
To participate in a Hebei Medical University Fourth Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hebei Medical University Fourth Hospital trials with current recruitment status updated daily.
Clinical Trials by Hebei Medical University Fourth Hospital
NCT06056115
Recruiting
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
Lung Adenocarcinoma
NCT06107673 Phase 2
Recruiting
Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
Breast Cancer
NCT06949111 Phase 2
Recruiting
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
Colon Cancer
NCT03964753 Phase 2
Recruiting
Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
NCT06210971 Phase 2
Recruiting
Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
Rectal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology